Literature DB >> 16873300

Usefulness of longitudinal measurements of beta-amyloid1-42 in cerebrospinal fluid of patients with various cognitive and neurologic disorders.

Femke H Bouwman, Wiesje M van der Flier, Niki S M Schoonenboom, Evert J van Elk, Astrid Kok, Philip Scheltens, Marinus A Blankenstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16873300     DOI： 10.1373/clinchem.2006.070193

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  6 in total

1.  Knowing the natural course of biomarkers in AD: longitudinal MRI, CSF and PET data.

Authors:  W M Van Der Flier; P Scheltens
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

Review 2.  CSF biomarkers for amyloid and tau pathology in Alzheimer's disease.

Authors:  Hanna Rosenmann
Journal:  J Mol Neurosci       Date:  2011-11-05       Impact factor: 3.444

3.  Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease.

Authors:  Maartje I Kester; Charlotte E Teunissen; Daniel L Crimmins; Elizabeth M Herries; Jack H Ladenson; Philip Scheltens; Wiesje M van der Flier; John C Morris; David M Holtzman; Anne M Fagan
Journal:  JAMA Neurol       Date:  2015-11       Impact factor: 18.302

4.  Measurement batch differences and between-batch conversion of Alzheimer's disease cerebrospinal fluid biomarker values.

Authors:  Yue Ma; Derek L Norton; Carol A Van Hulle; Richard J Chappell; Karen K Lazar; Erin M Jonaitis; Rebecca L Koscik; Lindsay R Clark; Rachel Krause; Ulf Andreasson; Nathaniel A Chin; Barbara B Bendlin; Sanjay Asthana; Ozioma C Okonkwo; Carey E Gleason; Sterling C Johnson; Henrik Zetterberg; Kaj Blennow; Cynthia M Carlsson
Journal:  Alzheimers Dement (Amst)       Date:  2021-05-25

Review 5.  Amsterdam Dementia Cohort: Performing Research to Optimize Care.

Authors:  Wiesje M van der Flier; Philip Scheltens
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort.

Authors:  Maartje I Kester; Charlotte E Teunissen; Courtney Sutphen; Elizabeth M Herries; Jack H Ladenson; Chengjie Xiong; Philip Scheltens; Wiesje M van der Flier; John C Morris; David M Holtzman; Anne M Fagan
Journal:  Alzheimers Res Ther       Date:  2015-09-17       Impact factor: 6.982
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.